Apollo, Carlyle, EQT team up with VC firms to tap biotech growth market

'Partnering with a team that is deeply versed in the science like Sofinnova is critical to meaningfully scale and accelerate our investment activity,' said Apollo's Neil Mehta.

ByAaron Weitzman

1 June 2022•8 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Western Europe Front page

Apollo, Carlyle, EQT team up with VC firms to tap biotech growth market

Sofinnova Partners

Abingworth

Apollo Global Management

EQT

The Carlyle Group

Related articles